img

Global Nucleic Acid Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Nucleic Acid Drugs Market Insights, Forecast to 2034

Nucleic Acid Drugs are pharmaceutical compounds that target nucleic acids (DNA or RNA) for therapeutic purposes, including gene therapy and antisense therapy.
Market Analysis and InsightsGlobal Nucleic Acid Drugs Market
Global Nucleic Acid Drugs market is expected to reach to US$ 97 million in 2023, with a positive growth of %, compared with US$ 76 million in 2023 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Nucleic Acid Drugs industry is evaluated to reach US$ 267.6 million in 2033. The CAGR will be 18.4% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2023, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2023. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2023. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Nucleic Acid Drugs market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Nucleic Acid Drugs market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Mina Therapeutics
BioNTech
NeXstar Pharmaceuticals
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Miragen Therapeutics
Segment by Type
Antisense Nucleic Acid Drugs
siRNA Drugs
saRNA Drugs
miRNA Drugs
mRNA Drugs
other

Segment by Application


Genetic Disease
Cancer
Cardiovascular Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Nucleic Acid Drugs introduction, etc. Nucleic Acid Drugs Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRA Research’s Conclusions of Nucleic Acid Drugs
Chapter 13Methodology and Data Sources adopted by MRA Research

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Drugs Market Size Growth Rate by Type, 2018 VS 2023 VS 2033
1.2.2 Antisense Nucleic Acid Drugs
1.2.3 siRNA Drugs
1.2.4 saRNA Drugs
1.2.5 miRNA Drugs
1.2.6 mRNA Drugs
1.2.7 other
1.3 Market by Application
1.3.1 Global Nucleic Acid Drugs Market Size Growth Rate by Application, 2018 VS 2023 VS 2033
1.3.2 Genetic Disease
1.3.3 Cancer
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Drugs Market Perspective (2018-2033)
2.2 Global Nucleic Acid Drugs Growth Trends by Region
2.2.1 Nucleic Acid Drugs Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Nucleic Acid Drugs Historic Market Size by Region (2018-2023)
2.2.3 Nucleic Acid Drugs Forecasted Market Size by Region (2024-2033)
2.3 Nucleic Acid Drugs Market Dynamics
2.3.1 Nucleic Acid Drugs Industry Trends
2.3.2 Nucleic Acid Drugs Market Drivers
2.3.3 Nucleic Acid Drugs Market Challenges
2.3.4 Nucleic Acid Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Nucleic Acid Drugs by Players
3.1.1 Global Nucleic Acid Drugs Revenue by Players (2018-2023)
3.1.2 Global Nucleic Acid Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nucleic Acid Drugs, Ranking by Revenue, 2021 VS 2023 VS 2023
3.4 Global Nucleic Acid Drugs Market Concentration Ratio
3.4.1 Global Nucleic Acid Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Drugs Revenue in 2023
3.5 Global Key Players of Nucleic Acid Drugs Head office and Area Served
3.6 Global Key Players of Nucleic Acid Drugs, Product and Application
3.7 Global Key Players of Nucleic Acid Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Drugs Breakdown Data by Type
4.1 Global Nucleic Acid Drugs Historic Market Size by Type (2018-2023)
4.2 Global Nucleic Acid Drugs Forecasted Market Size by Type (2024-2033)
5 Nucleic Acid Drugs Breakdown Data by Application
5.1 Global Nucleic Acid Drugs Historic Market Size by Application (2018-2023)
5.2 Global Nucleic Acid Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Nucleic Acid Drugs Market Size (2018-2033)
6.2 North America Nucleic Acid Drugs Market Size by Type
6.2.1 North America Nucleic Acid Drugs Market Size by Type (2018-2023)
6.2.2 North America Nucleic Acid Drugs Market Size by Type (2024-2033)
6.2.3 North America Nucleic Acid Drugs Market Share by Type (2018-2033)
6.3 North America Nucleic Acid Drugs Market Size by Application
6.3.1 North America Nucleic Acid Drugs Market Size by Application (2018-2023)
6.3.2 North America Nucleic Acid Drugs Market Size by Application (2024-2033)
6.3.3 North America Nucleic Acid Drugs Market Share by Application (2018-2033)
6.4 North America Nucleic Acid Drugs Market Size by Country
6.4.1 North America Nucleic Acid Drugs Market Size by Country: 2018 VS 2023 VS 2033
6.4.2 North America Nucleic Acid Drugs Market Size by Country (2018-2023)
6.4.3 North America Nucleic Acid Drugs Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Nucleic Acid Drugs Market Size (2018-2033)
7.2 Europe Nucleic Acid Drugs Market Size by Type
7.2.1 Europe Nucleic Acid Drugs Market Size by Type (2018-2023)
7.2.2 Europe Nucleic Acid Drugs Market Size by Type (2024-2033)
7.2.3 Europe Nucleic Acid Drugs Market Share by Type (2018-2033)
7.3 Europe Nucleic Acid Drugs Market Size by Application
7.3.1 Europe Nucleic Acid Drugs Market Size by Application (2018-2023)
7.3.2 Europe Nucleic Acid Drugs Market Size by Application (2024-2033)
7.3.3 Europe Nucleic Acid Drugs Market Share by Application (2018-2033)
7.4 Europe Nucleic Acid Drugs Market Size by Country
7.4.1 Europe Nucleic Acid Drugs Market Size by Country: 2018 VS 2023 VS 2033
7.4.2 Europe Nucleic Acid Drugs Market Size by Country (2018-2023)
7.4.3 Europe Nucleic Acid Drugs Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Nucleic Acid Drugs Market Size (2018-2033)
8.2 China Nucleic Acid Drugs Market Size by Type
8.2.1 China Nucleic Acid Drugs Market Size by Type (2018-2023)
8.2.2 China Nucleic Acid Drugs Market Size by Type (2024-2033)
8.2.3 China Nucleic Acid Drugs Market Share by Type (2018-2033)
8.3 China Nucleic Acid Drugs Market Size by Application
8.3.1 China Nucleic Acid Drugs Market Size by Application (2018-2023)
8.3.2 China Nucleic Acid Drugs Market Size by Application (2024-2033)
8.3.3 China Nucleic Acid Drugs Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Nucleic Acid Drugs Market Size (2018-2033)
9.2 Asia Nucleic Acid Drugs Market Size by Type
9.2.1 Asia Nucleic Acid Drugs Market Size by Type (2018-2023)
9.2.2 Asia Nucleic Acid Drugs Market Size by Type (2024-2033)
9.2.3 Asia Nucleic Acid Drugs Market Share by Type (2018-2033)
9.3 Asia Nucleic Acid Drugs Market Size by Application
9.3.1 Asia Nucleic Acid Drugs Market Size by Application (2018-2023)
9.3.2 Asia Nucleic Acid Drugs Market Size by Application (2024-2033)
9.3.3 Asia Nucleic Acid Drugs Market Share by Application (2018-2033)
9.4 Asia Nucleic Acid Drugs Market Size by Region
9.4.1 Asia Nucleic Acid Drugs Market Size by Region: 2018 VS 2023 VS 2033
9.4.2 Asia Nucleic Acid Drugs Market Size by Region (2018-2023)
9.4.3 Asia Nucleic Acid Drugs Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country: 2018 VS 2023 VS 2033
10.4.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Details
11.1.2 Sarepta Therapeutics Business Overview
11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Introduction
11.1.4 Sarepta Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023)
11.1.5 Sarepta Therapeutics Recent Developments
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Details
11.2.2 Ionis Pharmaceuticals Business Overview
11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Introduction
11.2.4 Ionis Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2018-2023)
11.2.5 Ionis Pharmaceuticals Recent Developments
11.3 Alnylam
11.3.1 Alnylam Company Details
11.3.2 Alnylam Business Overview
11.3.3 Alnylam Nucleic Acid Drugs Introduction
11.3.4 Alnylam Revenue in Nucleic Acid Drugs Business (2018-2023)
11.3.5 Alnylam Recent Developments
11.4 Mina Therapeutics
11.4.1 Mina Therapeutics Company Details
11.4.2 Mina Therapeutics Business Overview
11.4.3 Mina Therapeutics Nucleic Acid Drugs Introduction
11.4.4 Mina Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023)
11.4.5 Mina Therapeutics Recent Developments
11.5 BioNTech
11.5.1 BioNTech Company Details
11.5.2 BioNTech Business Overview
11.5.3 BioNTech Nucleic Acid Drugs Introduction
11.5.4 BioNTech Revenue in Nucleic Acid Drugs Business (2018-2023)
11.5.5 BioNTech Recent Developments
11.6 NeXstar Pharmaceuticals
11.6.1 NeXstar Pharmaceuticals Company Details
11.6.2 NeXstar Pharmaceuticals Business Overview
11.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Introduction
11.6.4 NeXstar Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2018-2023)
11.6.5 NeXstar Pharmaceuticals Recent Developments
11.7 Nippon Shinyaku
11.7.1 Nippon Shinyaku Company Details
11.7.2 Nippon Shinyaku Business Overview
11.7.3 Nippon Shinyaku Nucleic Acid Drugs Introduction
11.7.4 Nippon Shinyaku Revenue in Nucleic Acid Drugs Business (2018-2023)
11.7.5 Nippon Shinyaku Recent Developments
11.8 Moderna Therapeutics
11.8.1 Moderna Therapeutics Company Details
11.8.2 Moderna Therapeutics Business Overview
11.8.3 Moderna Therapeutics Nucleic Acid Drugs Introduction
11.8.4 Moderna Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023)
11.8.5 Moderna Therapeutics Recent Developments
11.9 CureVac
11.9.1 CureVac Company Details
11.9.2 CureVac Business Overview
11.9.3 CureVac Nucleic Acid Drugs Introduction
11.9.4 CureVac Revenue in Nucleic Acid Drugs Business (2018-2023)
11.9.5 CureVac Recent Developments
11.10 Regulus Therapeutics
11.10.1 Regulus Therapeutics Company Details
11.10.2 Regulus Therapeutics Business Overview
11.10.3 Regulus Therapeutics Nucleic Acid Drugs Introduction
11.10.4 Regulus Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023)
11.10.5 Regulus Therapeutics Recent Developments
11.11 Miragen Therapeutics
11.11.1 Miragen Therapeutics Company Details
11.11.2 Miragen Therapeutics Business Overview
11.11.3 Miragen Therapeutics Nucleic Acid Drugs Introduction
11.11.4 Miragen Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023)
11.11.5 Miragen Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Nucleic Acid Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Antisense Nucleic Acid Drugs
Table 3. Key Players of siRNA Drugs
Table 4. Key Players of saRNA Drugs
Table 5. Key Players of miRNA Drugs
Table 6. Key Players of mRNA Drugs
Table 7. Key Players of other
Table 8. Global Nucleic Acid Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 9. Global Nucleic Acid Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 10. Global Nucleic Acid Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Nucleic Acid Drugs Market Share by Region (2018-2023)
Table 12. Global Nucleic Acid Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Nucleic Acid Drugs Market Share by Region (2024-2033)
Table 14. Nucleic Acid Drugs Market Trends
Table 15. Nucleic Acid Drugs Market Drivers
Table 16. Nucleic Acid Drugs Market Challenges
Table 17. Nucleic Acid Drugs Market Restraints
Table 18. Global Nucleic Acid Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Nucleic Acid Drugs Revenue Share by Players (2018-2023)
Table 20. Global Top Nucleic Acid Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Drugs as of 2023)
Table 21. Global Nucleic Acid Drugs Industry Ranking 2021 VS 2023 VS 2023
Table 22. Global 5 Largest Players Market Share by Nucleic Acid Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 23. Global Key Players of Nucleic Acid Drugs, Headquarters and Area Served
Table 24. Global Key Players of Nucleic Acid Drugs, Product and Application
Table 25. Global Key Players of Nucleic Acid Drugs, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Nucleic Acid Drugs Revenue Market Share by Type (2018-2023)
Table 29. Global Nucleic Acid Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Nucleic Acid Drugs Revenue Market Share by Type (2024-2033)
Table 31. Global Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Nucleic Acid Drugs Revenue Share by Application (2018-2023)
Table 33. Global Nucleic Acid Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Nucleic Acid Drugs Revenue Share by Application (2024-2033)
Table 35. North America Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 36. North America Nucleic Acid Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 37. North America Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 38. North America Nucleic Acid Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 39. North America Nucleic Acid Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 40. North America Nucleic Acid Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America Nucleic Acid Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 42. Europe Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 43. Europe Nucleic Acid Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 44. Europe Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 45. Europe Nucleic Acid Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 46. Europe Nucleic Acid Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 47. Europe Nucleic Acid Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 48. Europe Nucleic Acid Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 49. China Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 50. China Nucleic Acid Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 51. China Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 52. China Nucleic Acid Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 54. Asia Nucleic Acid Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 55. Asia Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 56. Asia Nucleic Acid Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 57. Asia Nucleic Acid Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 58. Asia Nucleic Acid Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 59. Asia Nucleic Acid Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Nucleic Acid Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 65. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 67. Sarepta Therapeutics Company Details
Table 68. Sarepta Therapeutics Business Overview
Table 69. Sarepta Therapeutics Nucleic Acid Drugs Product
Table 70. Sarepta Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 71. Sarepta Therapeutics Recent Developments
Table 72. Ionis Pharmaceuticals Company Details
Table 73. Ionis Pharmaceuticals Business Overview
Table 74. Ionis Pharmaceuticals Nucleic Acid Drugs Product
Table 75. Ionis Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 76. Ionis Pharmaceuticals Recent Developments
Table 77. Alnylam Company Details
Table 78. Alnylam Business Overview
Table 79. Alnylam Nucleic Acid Drugs Product
Table 80. Alnylam Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 81. Alnylam Recent Developments
Table 82. Mina Therapeutics Company Details
Table 83. Mina Therapeutics Business Overview
Table 84. Mina Therapeutics Nucleic Acid Drugs Product
Table 85. Mina Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 86. Mina Therapeutics Recent Developments
Table 87. BioNTech Company Details
Table 88. BioNTech Business Overview
Table 89. BioNTech Nucleic Acid Drugs Product
Table 90. BioNTech Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 91. BioNTech Recent Developments
Table 92. NeXstar Pharmaceuticals Company Details
Table 93. NeXstar Pharmaceuticals Business Overview
Table 94. NeXstar Pharmaceuticals Nucleic Acid Drugs Product
Table 95. NeXstar Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 96. NeXstar Pharmaceuticals Recent Developments
Table 97. Nippon Shinyaku Company Details
Table 98. Nippon Shinyaku Business Overview
Table 99. Nippon Shinyaku Nucleic Acid Drugs Product
Table 100. Nippon Shinyaku Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 101. Nippon Shinyaku Recent Developments
Table 102. Moderna Therapeutics Company Details
Table 103. Moderna Therapeutics Business Overview
Table 104. Moderna Therapeutics Nucleic Acid Drugs Product
Table 105. Moderna Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 106. Moderna Therapeutics Recent Developments
Table 107. CureVac Company Details
Table 108. CureVac Business Overview
Table 109. CureVac Nucleic Acid Drugs Product
Table 110. CureVac Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 111. CureVac Recent Developments
Table 112. Regulus Therapeutics Company Details
Table 113. Regulus Therapeutics Business Overview
Table 114. Regulus Therapeutics Nucleic Acid Drugs Product
Table 115. Regulus Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 116. Regulus Therapeutics Recent Developments
Table 117. Miragen Therapeutics Company Details
Table 118. Miragen Therapeutics Business Overview
Table 119. Miragen Therapeutics Nucleic Acid Drugs Product
Table 120. Miragen Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 121. Miragen Therapeutics Recent Developments
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid Drugs Market Size Growth Rate by Type, 2018 VS 2023 VS 2033 (US$ Million)
Figure 2. Global Nucleic Acid Drugs Market Share by Type: 2023 VS 2033
Figure 3. Antisense Nucleic Acid Drugs Features
Figure 4. siRNA Drugs Features
Figure 5. saRNA Drugs Features
Figure 6. miRNA Drugs Features
Figure 7. mRNA Drugs Features
Figure 8. other Features
Figure 9. Global Nucleic Acid Drugs Market Size Growth Rate by Application, 2018 VS 2023 VS 2033 (US$ Million)
Figure 10. Global Nucleic Acid Drugs Market Share by Application: 2023 VS 2033
Figure 11. Genetic Disease Case Studies
Figure 12. Cancer Case Studies
Figure 13. Cardiovascular Diseases Case Studies
Figure 14. Other Case Studies
Figure 15. Nucleic Acid Drugs Report Years Considered
Figure 16. Global Nucleic Acid Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Nucleic Acid Drugs Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 18. Global Nucleic Acid Drugs Market Share by Region: 2023 VS 2033
Figure 19. Global Nucleic Acid Drugs Market Share by Players in 2023
Figure 20. Global Top Nucleic Acid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Drugs as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Nucleic Acid Drugs Revenue in 2023
Figure 22. North America Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Nucleic Acid Drugs Market Share by Type (2018-2033)
Figure 24. North America Nucleic Acid Drugs Market Share by Application (2018-2033)
Figure 25. North America Nucleic Acid Drugs Market Share by Country (2018-2033)
Figure 26. United States Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Nucleic Acid Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 29. Europe Nucleic Acid Drugs Market Share by Type (2018-2033)
Figure 30. Europe Nucleic Acid Drugs Market Share by Application (2018-2033)
Figure 31. Europe Nucleic Acid Drugs Market Share by Country (2018-2033)
Figure 32. Germany Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. China Nucleic Acid Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 39. China Nucleic Acid Drugs Market Share by Type (2018-2033)
Figure 40. China Nucleic Acid Drugs Market Share by Application (2018-2033)
Figure 41. Asia Nucleic Acid Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 42. Asia Nucleic Acid Drugs Market Share by Type (2018-2033)
Figure 43. Asia Nucleic Acid Drugs Market Share by Application (2018-2033)
Figure 44. Asia Nucleic Acid Drugs Market Share by Region (2018-2033)
Figure 45. Japan Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. South Korea Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. China Taiwan Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Southeast Asia Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. India Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Australia Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Type (2018-2033)
Figure 53. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Application (2018-2033)
Figure 54. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Country (2018-2033)
Figure 55. Brazil Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Mexico Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Turkey Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Israel Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. GCC Countries Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. Sarepta Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 62. Ionis Pharmaceuticals Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 63. Alnylam Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 64. Mina Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 65. BioNTech Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 66. NeXstar Pharmaceuticals Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 67. Nippon Shinyaku Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 68. Moderna Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 69. CureVac Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 70. Regulus Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 71. Miragen Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries